Is TB-500 Legal in Maryland? Federal Rules, State Law, and How to Get It
HealthRX.com
The peptide has no clear federal path for compounding in Maryland
See the public record for TB-500
At a glance
- FDA approval / none; no approved product in the United States, Canada, Australia, the UK, Belgium, Ireland, France, Norway, Germany, Spain or Italy, or authorized by the European Medicines Agency [1]
- FDA compounding lists / in none of the three interim-policy categories for state-licensed pharmacies; also absent from the outsourcing-facility list [2][3][4]
- Safety-risk page / in the 'nominated but withdrawn' table, not the active Category 2 table [7]
- Advisory committee / voted in favor of listing on July 23, 2026; advice only [8][5]
- HHS draft policy / names TB-500 acetate for injection; draft and non-binding [5][6]
- Sport / prohibited at all times under WADA S2.3 [9][10]
- Human data / FDA found no article in which TB-500 was given to a person [1]
What TB-500 is
A synthetic 7-amino-acid, N-acetylated fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4, about 889 g/mol. It is not full-length thymosin beta-4, and several salts and derivatives with different active moieties are sold under the same name [1]. FDA's July 2026 review found no USP or National Formulary monograph for it and no approved product in any of the countries it checked [1].
Can a pharmacy compound it?
Under the federal compounding statute, a state-licensed pharmacy may compound with a bulk substance only if it has a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [4]. TB-500 appears in none of the three categories of FDA's interim policy list for state-licensed pharmacies and physicians (updated May 14, 2026), and the policy of generally not acting against compounders does not cover it [2][4]. It is also absent from FDA's list for outsourcing facilities (updated March 21, 2025) [3]. It sits in the 'nominated but withdrawn' table on FDA's page about substances that may present significant safety risks, which holds substances previously in Category 2 whose nominators withdrew them; removal was not a safety finding [7]. FDA found no pharmacy marketing a compounded TB-500 product [1].
What happened in 2026
FDA's Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding TB-500 to the bulks list, against FDA staff's recommendation [8][5]. Staff had proposed not adding either the free base or the acetate, citing poor characterization, no human data and immunogenicity risk [1]. The vote is advice only, listing requires formal rulemaking, and TB-500 is not on the list [8][5].
HHS filed a draft enforcement-discretion policy on October 28, 2026 (Federal Register document 2026-22192; publication was scheduled for October 30, with comments due two weeks later) naming TB-500 among six peptides and covering the acetate form given by subcutaneous or intramuscular injection [5][6]. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it where its conditions are met, such as a single active ingredient, a patient-specific prescription, and material from an FDA-registered manufacturer with a certificate of analysis [5][6]. The notice says it creates no rights and is not binding on HHS or the public [5].
Does Maryland law change this?
FDA's compounding rules apply to state-licensed pharmacies and physicians in every state, Maryland included. No Maryland-specific rule on TB-500 is established on this page.
What people on Reddit report
These accounts discuss whether this peptide can be legally obtained, how a recent announcement is being read, and whether adults should have access despite risk.
No formal FDA rule has been published yet. The PCAC review meeting is July 23-24, 2026 that's when formal implementation moves forward.Read the source discussion
I don't think it's unreasonable for adults to have access to a legitimate, accurately labeled product even if there's some level of risk involved.Read the source discussion
There are plenty of "legal" sources for this. They just say "For research purposes only."Read the source discussion
Questions worth asking
Is it allowed in sport?
No. WADA's S2.3 names 'Thymosin-beta4 and its derivatives e.g. TB-500' and prohibits it at all times, in and out of competition; it is on the 2026 List and on the 2027 List [9][10].
What is known about TB-500 in people
FDA found no article in which TB-500 was given to a human, no approved dose and no human dosing study [1]. In an in-vitro scratch-wound test, TB-500 at 50 micrograms/mL did not induce wound closure in fibroblast cultures, while a shorter metabolite, N-acetylated LKKTE, showed activity [1]. Safety in humans is unknown: FDA found no nonclinical toxicity studies, no human pharmacokinetic data and no immunogenicity or aggregation studies, and its stated concern for injectable TB-500 is an immune reaction [1]. Its adverse-event database search through March 26, 2025 retrieved no TB-500 reports [1]. FDA also described a 40-year-old woman who used a 'research purposes only' BPC-157 plus TB-500 (5 mg/5 mg) product subcutaneously twice daily and developed widespread skin hyperpigmentation and gum darkening within a week, recurring when she retried it; because the product held two peptides, FDA said it could not tell whether either caused it [11].
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
Is TB-500 legal in Maryland?
Is TB-500 FDA-approved?
Can a compounding pharmacy legally make TB-500?
Did the FDA advisory committee vote to allow TB-500?
Does the HHS draft peptide policy make TB-500 legal?
Is TB-500 banned in sport?
References
Show all 13 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Official web page.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- World Anti-Doping Agency.
- U.S. Food and Drug Administration.
- Reddit participants. RFK Jr. Just Announced 14 Peptides Are Coming Back to Legal Status Including BPC-157, TB-500, Ipamorelin, and CJC-1295. Here's What Actually (r/DiscussionZone). Accessed 2026-11-11.
- Reddit participants. FDA Unbans 14 Peptides for Legal US Compounding! (r/Biohackers). Accessed 2026-11-11.